GlassScriptPhysician profile
Amanda S Wiles
NPI 1144568767
$2,570.54
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
See the full distribution for Occupational Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $406 · 2022: $532 · 2023: $920 · 2024: $713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,633.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $927.91 | 2021-2024 | |
| Janssen Biotech, INC. | $262.54 | 2021-2024 | Stelara, Simponi, Simponi Aria |
| Harmony Biosciences LLC | $261.33 | 2022-2024 | Wakix |
| Celgene Corporation | $202.31 | 2021-2024 | Zeposia |
| Astrazeneca Pharmaceuticals LP | $187.31 | 2022-2024 | Airsupra, Fasenra, Breztri |
| Melinta Therapeutics, LLC | $122.32 | 2022-2024 | Orbactiv, Kimyrsa, Vabomere |
| Janssen Pharmaceuticals, INC | $68.60 | 2021-2024 | Xarelto |
| Pfizer INC. | $65.88 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $62.56 | 2022-2024 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $54.56 | 2022-2024 | Eohilia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.98 | 2022-2023 | Ofev |
| Baxter Healthcare | $46.41 | 2023-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Merck Sharp & Dohme LLC | $37.60 | 2023 | Recarbrio, Zerbaxa, Dificid |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.89 | 2021 | |
| United Therapeutics Corporation | $29.66 | 2023 | Tyvaso |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Octapharma USA, INC. | $22.15 | 2021 | |
| Qol Medical, LLC | $19.58 | 2023 | Sucraid |
| Aimmune Therapeutics, INC. | $17.18 | 2024 | |
| Nestle Healthcare Nutrition INC. | $16.46 | 2023 | |
| Mallinckrodt Hospital Products INC. | $16.26 | 2024 | Acthar |
| Pharming Healthcare, INC. | $14.06 | 2023 | Ruconest |
| Mylan Specialty L.P. | $13.50 | 2021 | |
| Genzyme Corporation | $13.28 | 2024 | |
| Grifols USA, LLC | $12.24 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $9.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Wiles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.